We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.


Clear all

Refine your search

Content type

3 results found


Bereskin & Parr LLP | USA | 17 Sep 2013

Myriad Genetics holding that cDNA is patent-eligible subject matter is good news for those seeking or enforcing patents for computer-implemented technologies

On June 13, 2013, the Supreme Court of the United States issued its decision in the Association for Molecular Pathology et al. v. Myriad Genetics

Previous page 1 Next page